HIMS & HERS HEALTH, INC. vs Privia Health Group, Inc., two Medical Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where HIMS and PRVA diverge most: on operating margin, HIMS reads -12.9% and PRVA reads 1.9%; on net margin, HIMS reads -5.5% and PRVA reads 1.2%. The rest of the comparable metrics sit closer together. What PRVA's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | HIMS | PRVA |
|---|---|---|
| Price | $30.91 | $20.85 |
| Market cap | $7.2B | $2.7B |
| Sector | Medical Services | Medical Services |
| Stage | Growth | Growth |
| P/E | — | 94.8 |
| P/B | 22.10 | 3.28 |
| P/S | 2.78 | 1.17 |
| EV/EBITDA | — | 41.0 |
| Revenue growth | +29.9% | +24.3% |
| Gross margin | 63.8% | — |
| Operating margin | -12.9% | 1.9% |
| Net margin | -5.5% | 1.2% |
| Return on equity | -43.8% | 3.4% |
| Return on assets | -3.9% | 1.9% |
| Return on invested capital | -7.2% | 3.1% |
| FCF yield | 0.9% | 4.8% |
| Debt / equity | 4.21 | 0.00 |
| Current ratio | 0.93 | 1.62 |
| Altman Z (solvency) | 1.78 | 4.32 |
| Piotroski F (quality) | 4 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.